Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRIO-II: Brimochol PF in Presbyopia
NCT05135286Phase 3Completed
- Sponsor
- Tenpoint Therapeutics
- Start
- Mar 2022
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of BRIMOCHOL in presbyopia, sponsored by Tenpoint Therapeutics. Started Mar 2022; status: completed.
02
Drugs
BRIMOCHOL
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT05135286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05135286.